|
1
|
Ferlay JEM, Lam F, Colombet M, Mery L,
Piñeros M, Znaora, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer; Lyon, France: 2020
|
|
2
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang R, Pan W, Jin L, Huang W, Li Y, Wu D,
Gao C, Ma D and Liao S: Human papillomavirus vaccine against
cervical cancer: Opportunity and challenge. Cancer Lett.
471:88–102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hermyt E, Zmarzły N, Grabarek B,
Kruszniewska-Rajs C, Gola J, Jęda-Golonka A, Szczepanek K, Mazurek
U and Witek A: Interplay between miRNAs and Genes Associated with
Cell Proliferation in Endometrial Cancer. Int J Mol Sci.
20:E60112019. View Article : Google Scholar
|
|
5
|
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ
and Chen YT: Cancer/testis antigens: An expanding family of targets
for cancer immunotherapy. Immunol Rev. 188:22–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cocchia M, Huber R, Pantano S, Chen EY, Ma
P, Forabosco A, Ko MS and Schlessinger D: PLAC1, an Xq26 gene with
placenta-specific expression. Genomics. 68:305–312. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fant ME, Fuentes J, Kong X and Jackman S:
The nexus of prematurity, birth defects, and intrauterine growth
restriction: A role for plac1-regulated pathways. Front Pediatr.
2:82014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Baddoo MC and Yin Q: The placental
specific gene, PLAC1, is induced by the Epstein-Barr virus and is
expressed in human tumor cells. Virol J. 11:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koslowski M, Sahin U, Mitnacht-Kraus R,
Seitz G, Huber C and Türeci O: A placenta-specific gene ectopically
activated in many human cancers is essentially involved in
malignant cell processes. Cancer Res. 67:9528–9534. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Devor EJ: Placenta-specific protein 1
(PLAC1) is a unique onco-fetal-placental protein and an
underappreciated therapeutic target in cancer(J). Integr Cancer Sci
Ther. 3:479–483. 2016. View Article : Google Scholar
|
|
11
|
Dong XY, Peng JR, Ye YJ, Chen HS, Zhang
LJ, Pang XW, Li Y, Zhang Y, Wang S, Fant ME, et al: Plac1 is a
tumor-specific antigen capable of eliciting spontaneous antibody
responses in human cancer patients. Int J Cancer. 122:2038–2043.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Pang XW, Liu FF, Dong XY, Wang HC,
Wang S, Zhang Y and Chen WF: PLAC1/CP1 gene expression and
autologous humoral immunity in gastric cancer patients. Beijing Da
Xue Xue Bao. 38:124–127. 2006.PubMed/NCBI
|
|
13
|
Devor EJ, Reyes HD, Gonzalez-Bosquet J,
Warrier A, Kenzie SA, Ibik NV, Miller MD, Schickling BM, Goodheart
MJ, Thiel KW, et al: Placenta-specific protein 1 expression in
human papillomavirus 16/18-positive cervical cancers is associated
with tumor histology. Int J Gynecol Cancer. 27:784–790. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jackman SM, Kong X and Fant ME: Plac1
(placenta-specific 1) is essential for normal placental and
embryonic development. Mol Reprod Dev. 79:564–572. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Old LJ: Cancer is a somatic cell
pregnancy. Cancer Immun. 7:192007.PubMed/NCBI
|
|
16
|
Cheever MA, Allison JP, Ferris AS, Finn
OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL,
Weiner LM, et al: The prioritization of cancer antigens: A national
cancer institute pilot project for the acceleration of
translational research. Clin Cancer Res. 15:5323–5337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
GDC Data User's Guide(EB/OL):
(2021.08.19), . https://docs.gdc.cancer.gov/Data/PDF/Data_UG.pdf
|
|
18
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES, et al: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The Molecular Signatures
Database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
R Core Team R, . A Language And
Environment For Statistical Computing. R Foundation For Statistical
Computing; Vienna: 2018
|
|
22
|
Goel MK, Khanna P and Kishore J:
Understanding survival analysis: Kaplan-Meier estimate. Int J
Ayurveda Res. 1:274–278. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bradley SD, Talukder AH, Lai I, Davis R,
Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, et
al: Vestigial-like 1 is a shared targetable cancer-placenta antigen
expressed by pancreatic and basal-like breast cancers. Nat Commun.
11:53322020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mittal V: Epithelial mesenchymal
transition in tumor metastasis. Annu Rev Pathol. 13:395–412. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goossens S, Vandamme N, Van Vlierberghe P
and Berx G: EMT transcription factors in cancer development
re-evaluated: Beyond EMT and MET. Biochim Biophys Acta Rev Cancer.
1868:584–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu F, Shen D, Kang X, Zhang C and Song Q:
New tumour antigen PLAC1/CP1, a potentially useful prognostic
marker and immunotherapy target for gastric adenocarcinoma. J Clin
Pathol. 68:913–916. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Y, Lin X, Di X, Chen Y, Zhao H and Wang
X: Oncogenic function of Plac1 on the proliferation and metastasis
in hepatocellular carcinoma cells. Oncol Rep. 37:465–473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu FF, Dong XY, Pang XW, Xing Q, Wang HC,
Zhang HG, Li Y, Yin YH, Fant M, Ye YJ, et al: The specific immune
response to tumor antigen CP1 and its correlation with improved
survival in colon cancer patients. Gastroenterology. 134:998–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tchabo NE, Mhawech-Fauceglia P, Caballero
OL, Villella J, Beck AF, Miliotto AJ, Liao J, Andrews C, Lele S,
Old LJ, et al: Expression and serum immunoreactivity of
developmentally restricted differentiation antigens in epithelial
ovarian cancer. Cancer Immun. 9:62009.PubMed/NCBI
|
|
30
|
Devor EJ and Leslie KK: The oncoplacental
gene placenta-specific protein 1 is highly expressed in endometrial
tumors and cell lines. Obstet Gynecol Int. 2013:8078492013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ghods R, Ghahremani MH, Madjd Z, Asgari M,
Abolhasani M, Tavasoli S, Mahmoudi AR, Darzi M, Pasalar P,
Jeddi-Tehrani M, et al: High placenta-specific 1/low
prostate-specific antigen expression pattern in high-grade prostate
adenocarcinoma. Cancer Immunol Immunother. 63:1319–1327. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pópulo H, Lopes JM and Soares P: The mTOR
signalling pathway in human cancer. Int J Mol Sci. 13:1886–1918.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kremer CL, Klein RR, Mendelson J, Browne
W, Samadzedeh LK, Vanpatten K, Highstrom L, Pestano GA and Nagle
RB: Expression of mTOR signaling pathway markers in prostate cancer
progression. Prostate. 66:1203–1212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Chang L, Li Z, Gao Q, Cai D, Tian
Y, Zeng L and Li M: miR-99a and −99b inhibit cervical cancer cell
proliferation and invasion by targeting mTOR signaling pathway. Med
Oncol. 31:9342014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rashmi R, DeSelm C, Helms C, Bowcock A,
Rogers BE, Rader JL, Grigsby PW and Schwarz JK: AKT inhibitors
promote cell death in cervical cancer through disruption of mTOR
signaling and glucose uptake. PLoS One. 9:e929482014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kirkwood J: Cancer immunotherapy: The
interferon-alpha experience. Semin Oncol. 29:18–26. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kretzmann NA, Chiela E, Matte U, Marroni N
and Marroni CA: N-acetylcysteine improves antitumoural response of
Interferon alpha by NF-κB downregulation in liver cancer cells.
Comp Hepatol. 11:42012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Thomas GV, Tran C, Mellinghoff IK, Welsbie
DS, Chan E, Fueger B, Czernin J and Sawyers CL: Hypoxia-inducible
factor determines sensitivity to inhibitors of mTOR in kidney
cancer. Nat Med. 12:122–127. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pilch H, Schlenger K, Steiner E,
Brockerhoff P, Knapstein P and Vaupel P: Hypoxia-stimulated
expression of angiogenic growth factors in cervical cancer cells
and cervical cancer-derived fibroblasts. Int J Gynecol Cancer.
11:137–142. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aiello NM, Maddipati R, Norgard RJ, Balli
D, Li J, Yuan S, Yamazoe T, Black T, Sahmoud A, Furth EE, et al:
EMT subtype influences epithelial plasticity and mode of cell
migration. Dev Cell. 45:681–695.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lee JY and Kong G: Roles and epigenetic
regulation of epithelial-mesenchymal transition and its
transcription factors in cancer initiation and progression. Cell
Mol Life Sci. 73:4643–4660. 2016. View Article : Google Scholar : PubMed/NCBI
|
